NEW YORK, April 12 – DNAPrint Genomics announced Thursday that it had signed an agreement with Acculab to collect blood specimens from volunteers that can then be analyzed to determine the relationship between SNPs and particular drug reactions. 

The deal is the third collaboration DNAPrint Genomics of Sarasota, Fla., has forged in its effort to collect blood samples from Florida residents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.